This report was recently updated on November 15 2024 with the latest and most recent
market numbers
Global Hypothermic Perfusion Preservation Market Size, Trends & Analysis - Forecasts to 2028 By End User (Hospitals, Organ Procurement Organizations (OPOs), and Transplant Centres), By Organ Type (Heart, Lungs, Liver, Kidneys, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global hypothermic perfusion preservation market is expected to grow at a CAGR of 9.5% from 2023 to 2028. Hypothermic perfusion preservation is a technique used in organ transplantation and storage to preserve organs at low temperatures, typically around 0-4 degrees Celsius. This method involves pumping a preservation solution through the blood vessels of the organ, which helps to maintain the organ's viability and function during the storage period. The solution used in hypothermic perfusion preservation typically contains a combination of electrolytes, antioxidants, and other agents that help minimize cellular damage and maintain the organ's metabolic functions.
Many market drivers affect the growth of the hypothermic perfusion preservation market positively. The rising incidence of organ damage and the increased demand for organ transplantation operations have both contributed considerably to the growth of the hypothermic perfusion preservation market. As the number of patients in need of organ transplants continues to increase globally, the demand for effective organ preservation techniques such as hypothermic perfusion preservation is also expected to rise. The continual rise in healthcare spending in developed and developing nations also contributes to hypothermic perfusion preservation market growth. Increased investments in healthcare infrastructure, including organ transplant facilities, have facilitated the adoption of advanced preservation techniques, propelling the market growth. Continuous advancements in biomedical research, including studies focused on improving organ preservation techniques, have provided valuable insights for enhancing the efficacy of hypothermic perfusion preservation. The integration of cutting-edge research findings into the development of preservation solutions and techniques also drives market growth.
Despite its immense potential, the global hypothermic perfusion preservation market faces several notable constraints. The initial expenditure and continuous operating costs for hypothermic perfusion preservation devices are very high. The expenses related to equipment procurement, maintenance, and the procurement of specialized preservation solutions pose a significant financial burden, limiting the adoption of these technologies, particularly in resource-constrained healthcare settings. In several developing regions like the Sub-Saharan regions and some Latin American countries, the lack of advanced healthcare infrastructure and the limited availability of skilled healthcare professionals hinders the widespread adoption of hypothermic perfusion preservation techniques. The absence of adequate facilities for organ transplantation and preservation may impede market growth in these regions.
Based on end user, the market is segmented into hospitals, organ procurement organizations (OPOs), and transplant centres. The hospital segment is expected to dominate the market during the forecast period. Hospitals serve as key centres for organ retrieval, preservation, and transplantation, necessitating hypothermic perfusion preservation techniques to maintain organ viability. With the increasing prevalence of chronic diseases and the rising demand for organ transplantation, hospitals remain primary hubs for these critical medical interventions, contributing to the significant market share of the hospital segment in the hypothermic perfusion preservation market.
The transplant centres segment is expected to be the fastest-growing segment in the global hypothermic perfusion preservation market. These specialized centres demand advanced preservation techniques to ensure the viability of organs during transportation and transplantation. Moreover, the rising prevalence of chronic diseases and organ failures has propelled the need for efficient organ preservation, driving the adoption of hypothermic perfusion preservation systems in transplant centres, thereby fuelling the segment's rapid growth.
On the basis of organ type, the market is segmented into heart, lungs, liver, kidneys, and others. The kidney segment is expected to be the largest segment during the forecast period due to the high prevalence of end-stage renal disease and the subsequent demand for kidney transplants globally. The growing incidence of conditions such as diabetes and hypertension, which can lead to kidney failure, has further bolstered the need for efficient preservation techniques. Additionally, advancements in hypothermic perfusion preservation technology have significantly improved the success rates of kidney transplantation, solidifying the dominance of the kidney segment in the market.
The heart segment is expected to be the fastest-growing segment in the global hypothermic perfusion preservation market over the forecast period due to the high prevalence of cardiovascular diseases globally, leading to an increased demand for heart transplants. Additionally, technological advancements in hypothermic perfusion preservation techniques have improved the viability of heart preservation, enhancing successful transplantation rates. With a rising geriatric population and lifestyle-related cardiac ailments, the need for efficient heart preservation solutions has intensified, driving the rapid growth of the heart segment in the market.
North America is analysed to be the region with the largest share in the global hypothermic perfusion preservation market during the forecast period. The healthcare system in North America is firmly established, and organ transplant operations are common. Furthermore, the region has been at the forefront of medical research and technical innovation, which has resulted in the development and implementation of improved organ preservation procedures. Furthermore, favourable reimbursement policies, increased awareness about organ donation, and a relatively higher healthcare expenditure contribute to the prominence of the North America market in this sector.
Asia Pacific is projected to be the fastest-growing region across the global hypothermic perfusion preservation market over the forecast period. Rapid advancements in healthcare infrastructure, increasing investment in medical research, a rising prevalence of chronic diseases, and expanding initiatives to promote organ transplantation are propelling market growth. Additionally, the region's large population, coupled with a growing geriatric demographic, drives the demand for efficient organ preservation techniques, fostering the rapid adoption of hypothermic perfusion preservation technologies in the APAC region.
Key players operating in the global hypothermic perfusion preservation market include Organ Recovery Systems, XVIVO Perfusion, Paragonix Technologies, TransMedics, Bridge to Life Ltd., Preservation Solutions Inc., OrganOx, Organ Assist, Waters Medical Systems LLC, and Preservation Sciences Inc., among others.
Please note: This is not an exhaustive list of companies profiled in the report.
In August 2023, Bridge to Life Ltd. divested assets to TransMedics, including EVOSS heart and lung and LifeCradle heart perfusion assets, to focus on core preservation solutions and pending U.S. FDA submission for VitaSmart Liver Machine Perfusion System.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market OpportunIties: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL HYPOTHERMIC PERFUSION PRESERVATION MARKET, BY END USER
4.1 Introduction
4.2 Global Hypothermic Perfusion Preservation Market: End User Scope Key Takeaways
4.3 Revenue Growth Analysis, 2022 & 2028
4.4 Hospitals
4.4.1 Hospitals Market Estimates and Forecast, 2020-2028 (USD Billion)
4.5 Organ Procurement Organizations (OPOs)
4.5.1 Organ Procurement Organizations (OPOs) Market Estimates and Forecast, 2020-2028 (USD Billion)
4.6 Transplant Centres
4.6.1 Transplant Centres Market Estimates and Forecast, 2020-2028 (USD Billion)
5 GLOBAL HYPOTHERMIC PERFUSION PRESERVATION MARKET, BY ORGAN TYPE
5.1 Introduction
5.2 Global Hypothermic Perfusion Preservation Market: Organ Type Scope Key Takeaways
5.3 Revenue Growth Analysis, 2022 & 2028
5.4 Heart
5.4.1 Heart Market Estimates And Forecast, 2020-2028 (USD Billion)
5.5 Lungs
5.5.1 Lungs Market Estimates And Forecast, 2020-2028 (USD Billion)
5.6 Liver
5.6.1 Liver Market Estimates And Forecast, 2020-2028 (USD Billion)
5.7 Kidney
5.7.1 Kidney Market Estimates And Forecast, 2020-2028 (USD Billion)
5.8 Other Organs
5.8.1 Other Organs Market Estimates And Forecast, 2020-2028 (USD Billion)
6 GLOBAL HYPOTHERMIC PERFUSION PRESERVATION MARKET, BY REGION
6.1 Introduction
6.2 North America Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.2.1 By End User
6.2.2 By Organ Type
6.2.3 By Country
6.2.3.1 U.S. Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.2.3.1.1 By End User
6.2.3.1.2 By Organ Type
6.2.3.2 Canada Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.2.3.2.1 By End User
6.2.3.2.2 By Organ Type
6.2.3.3 Mexico Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.2.3.3.1 By End User
6.2.3.3.2 By Organ Type
6.3 Europe Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.1 By End User
6.3.2 By Organ Type
6.3.3 By Country
6.3.3.1 Germany Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.1.1 By End User
6.3.3.1.2 By Organ Type
6.3.3.2 U.K. Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.2.1 By End User
6.3.3.2.2 By Organ Type
6.3.3.3 France Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.3.1 By End User
6.3.3.3.2 By Organ Type
6.3.3.4 Italy Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.4.1 By End User
6.3.3.4.2 By Organ Type
6.3.3.5 Spain Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.5.1 By End User
6.3.3.5.2 By Organ Type
6.3.3.6 Netherlands Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.6.1 By End User
6.3.3.6.2 By Organ Type
6.3.3.7 Rest of Europe Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.6.1 By End User
6.3.3.6.2 By Organ Type
6.4 Asia Pacific Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.1 By End User
6.4.2 By Organ Type
6.4.3 By Country
6.4.3.1 China Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.1.1 By End User
6.4.3.1.2 By Organ Type
6.4.3.2 Japan Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.2.1 By End User
6.4.3.2.2 By Organ Type
6.4.3.3 India Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.3.1 By End User
6.4.3.3.2 By Organ Type
6.4.3.4 South Korea Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.4.1 By End User
6.4.3.4.2 By Organ Type
6.4.3.5 Singapore Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.5.1 By End User
6.4.3.5.2 By Organ Type
6.4.3.6 Malaysia Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.6.1 By End User
6.4.3.6.2 By Organ Type
6.4.3.7 Thailand Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.6.1 By End User
6.4.3.6.2 By Organ Type
6.4.3.8 Indonesia Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.7.1 By End User
6.4.3.7.2 By Organ Type
6.4.3.9 Vietnam Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.8.1 By End User
6.4.3.8.2 By Organ Type
6.4.3.10 Taiwan Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.10.1 By End User
6.4.3.10.2 By Organ Type
6.4.3.11 Rest of Asia Pacific Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.11.1 By End User
6.4.3.11.2 By Organ Type
6.5 Middle East and Africa Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5.1 By End User
6.5.2 By Organ Type
6.5.3 By Country
6.5.3.1 Saudi Arabia Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5.3.1.1 By End User
6.5.3.1.2 By Organ Type
6.5.3.2 U.A.E. Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5.3.2.1 By End User
6.5.3.2.2 By Organ Type
6.5.3.3 Israel Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5.3.3.1 By End User
6.5.3.3.2 By Organ Type
6.5.3.4 South Africa Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5.3.4.1 By End User
6.5.3.4.2 By Organ Type
6.5.3.5 Rest of Middle East and Africa Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5.3.5.1 By End User
6.5.3.5.2 By Organ Type
6.6 Central and South America Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.6.1 By End User
6.6.2 By Organ Type
6.6.3 By Country
6.6.3.1 Brazil Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.6.3.1.1 By End User
6.6.3.1.2 By Organ Type
6.6.3.2 Argentina Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.6.3.2.1 By End User
6.6.3.2.2 By Organ Type
6.6.3.3 Chile Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.6.3.3.1 By End User
6.6.3.3.2 By Organ Type
6.6.3.3 Rest of Central and South America Hypothermic Perfusion Preservation Market Estimates and Forecast, 2020-2028 (USD Billion)
6.6.3.3.1 By End User
6.6.3.3.2 By Organ Type
7 COMPETITIVE LANDCAPE
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.2.1 Market Leaders
7.2.2 Market Visionaries
7.2.3 Market Challengers
7.2.4 Niche Market Players
7.3 Vendor Landscape
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Rest of the World
7.4 Company Profiles
7.4.1 Organ Recovery Systems
7.4.1.1 Business Description & Financial Analysis
7.4.1.2 SWOT Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2 XVIVO Perfusion
7.4.2.1 Business Description & Financial Analysis
7.4.2.2 SWOT Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 Paragonix Technologies
7.4.3.1 Business Description & Financial Analysis
7.4.3.2 SWOT Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4 TransMedics
7.4.4.1 Business Description & Financial Analysis
7.4.4.2 SWOT Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5 Bridge to Life Ltd.
7.4.5.1 Business Description & Financial Analysis
7.4.5.2 SWOT Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6 Preservation Solutions, Inc.
7.4.6.1 Business Description & Financial Analysis
7.4.6.2 SWOT Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 OrganOx
7.4.7.1 Business Description & Financial Analysis
7.4.7.2 SWOT Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8 Organ Assist
7.4.8.1 Business Description & Financial Analysis
7.4.8.2 SWOT Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9 Waters Medical Systems LLC
7.4.9.1 Business Description & Financial Analysis
7.4.9.2 SWOT Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 Preservation Sciences, Inc.
7.4.10.1 Business Description & Financial Analysis
7.4.10.2 SWOT Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11 Other Companies
7.4.11.1 Business Description & Financial Analysis
7.4.11.2 SWOT Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8 RESEARCH METHODOLOGY
8.1 Market Introduction
8.1.1 Market Definition
8.1.2 Market Scope & Segmentation
8.2 Information Procurement
8.2.1 Secondary Research
8.2.1.1 Purchased Databases
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company Information Sources
8.2.2 Primary Research
8.2.2.1 Various Types of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.3 Primary Stakeholders
8.2.2.4 Discussion Guide for Primary Participants
8.2.3 Expert Panels
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4 Paid Local Experts
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3 Market Estimation
8.3.1 Top-Down Approach
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2 Bottom Up Approach
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4 Data Triangulation
8.4.1 Data Collection
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.4.3 Cluster Analysis
8.5 Analysis and Output
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
8.6.1 Research Assumptions
8.6.2 Research Limitations
LIST OF TABLES
1 Global Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
2 Hospitals Market, By Region, 2020-2028 (USD Billion)
3 Organ Procurement Organizations (OPOs) Market, By Region, 2020-2028 (USD Billion)
4 Transplant Centres Market, By Region, 2020-2028 (USD Billion)
5 Global Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
6 Heart Market, By Region, 2020-2028 (USD Billion)
7 Lungs Market, By Region, 2020-2028 (USD Billion)
8 Liver Market, By Region, 2020-2028 (USD Billion)
9 Kidney Market, By Region, 2020-2028 (USD Billion)
10 Other Organs Market, By Region, 2020-2028 (USD Billion)
11 Regional Analysis, 2020-2028 (USD Billion)
12 North America Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
13 North America Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
14 U.S. Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
15 U.S. Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
16 Canada Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
17 Canada Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
18 Mexico Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
19 Mexico Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
20 Europe Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
21 Europe Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
22 Germany Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
23 Germany Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
24 U.K. Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
25 U.K. Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
26 France Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
27 France Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
28 Italy Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
29 Italy Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
30 Spain Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
31 Spain Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
32 Netherlands Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
33 Netherlands Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
34 Rest Of Europe Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
35 Rest Of Europe Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
36 Asia Pacific Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
37 Asia Pacific Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
38 China Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
39 China Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
40 Japan Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
41 Japan Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
42 India Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
43 India Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
44 South Korea Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
45 South Korea Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
46 Singapore Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
47 Singapore Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
48 Thailand Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
49 Thailand Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
50 Malaysia Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
51 Malaysia Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
52 Indonesia Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
53 Indonesia Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
54 Vietnam Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
55 Vietnam Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
56 Taiwan Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
57 Taiwan Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
58 Rest of APAC Global Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
59 Rest of APAC Global Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
60 Middle East and Africa Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
61 Middle East and Africa Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
62 Saudi Arabia Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
63 Saudi Arabia Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
64 UAE Global Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
65 UAE Global Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
66 Israel Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
67 Israel Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
68 South Africa Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
69 South Africa Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
70 Rest Of Middle East and Africa Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
71 Rest Of Middle East and Africa Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
72 Central and South America Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
73 Central and South America Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
74 Brazil Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
75 Brazil Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
76 Chile Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
77 Chile Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
78 Argentina Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
79 Argentina Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
80 Rest Of Central and South America Hypothermic Perfusion Preservation Market, By End User, 2020-2028 (USD Billion)
81 Rest Of Central and South America Hypothermic Perfusion Preservation Market, By Organ Type, 2020-2028 (USD Billion)
82 Organ Recovery Systems: Products & Services Offering
83 XVIVO Perfusion: Products & Services Offering
84 Paragonix Technologies: Products & Services Offering
85 TRANSMEDICS: Products & Services Offering
86 Bridge to Life Ltd.: Products & Services Offering
87 PRESERVATION SOLUTIONS, INC.: Products & Services Offering
88 OrganOx: Products & Services Offering
89 Organ Assist: Products & Services Offering
90 Waters Medical Systems LLC: Products & Services Offering
91 Preservation Sciences, Inc.: Products & Services Offering
92 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Hypothermic Perfusion Preservation Market Overview
2 Global Hypothermic Perfusion Preservation Market Value From 2020-2028 (USD Billion)
3 Global Hypothermic Perfusion Preservation Market Share, By End User (2022)
4 Global Hypothermic Perfusion Preservation Market Share, By Organ Type (2022)
5 Global Hypothermic Perfusion Preservation Market, By Region (Asia Pacific Market)
6 Technological Trends In Global Hypothermic Perfusion Preservation Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The Global Hypothermic Perfusion Preservation Market
10 Impact Of Challenges On The Global Hypothermic Perfusion Preservation Market
11 Porter’s Five Forces Analysis
12 Global Hypothermic Perfusion Preservation Market: By End User Scope Key Takeaways
13 Global Hypothermic Perfusion Preservation Market, By End User Segment: Revenue Growth Analysis
14 Hospitals Market, By Region, 2020-2028 (USD Billion)
15 Organ Procurement Organizations (OPOs) Market, By Region, 2020-2028 (USD Billion)
16 Transplant Centres Market, By Region, 2020-2028 (USD Billion)
17 Global Hypothermic Perfusion Preservation Market: By Organ Type Scope Key Takeaways
18 Global Hypothermic Perfusion Preservation Market, By Organ Type Segment: Revenue Growth Analysis
19 Heart Market, By Region, 2020-2028 (USD Billion)
20 Lungs Market, By Region, 2020-2028 (USD Billion)
21 Liver Market, By Region, 2020-2028 (USD Billion)
22 Kidney Market, By Region, 2020-2028 (USD Billion)
23 Other Organs Market, By Region, 2020-2028 (USD Billion)
24 Regional Segment: Revenue Growth Analysis
25 Global Hypothermic Perfusion Preservation Market: Regional Analysis
26 North America Hypothermic Perfusion Preservation Market Overview
27 North America Hypothermic Perfusion Preservation Market, By End User
28 North America Hypothermic Perfusion Preservation Market, By Organ Type
29 North America Hypothermic Perfusion Preservation Market, By Country
30 U.S. Hypothermic Perfusion Preservation Market, By End User
31 U.S. Hypothermic Perfusion Preservation Market, By Organ Type
32 Canada Hypothermic Perfusion Preservation Market, By End User
33 Canada Hypothermic Perfusion Preservation Market, By Organ Type
34 Mexico Hypothermic Perfusion Preservation Market, By End User
35 Mexico Hypothermic Perfusion Preservation Market, By Organ Type
36 Four Quadrant Positioning Matrix
37 Company Market Share Analysis
38 Organ Recovery Systems: Company Snapshot
39 Organ Recovery Systems: SWOT Analysis
40 Organ Recovery Systems: Geographic Presence
41 XVIVO Perfusion: Company Snapshot
42 XVIVO Perfusion: SWOT Analysis
43 XVIVO Perfusion: Geographic Presence
44 Paragonix Technologies: Company Snapshot
45 Paragonix Technologies: SWOT Analysis
46 Paragonix Technologies: Geographic Presence
47 TransMedics: Company Snapshot
48 TransMedics: SWOT Analysis
49 TransMedics: Geographic Presence
50 Bridge to Life Ltd.: Company Snapshot
51 Bridge to Life Ltd.: SWOT Analysis
52 Bridge to Life Ltd.: Geographic Presence
53 Preservation Solutions, Inc.: Company Snapshot
54 Preservation Solutions, Inc.: SWOT Analysis
55 Preservation Solutions, Inc.: Geographic Presence
56 OrganOx: Company Snapshot
57 OrganOx: SWOT Analysis
58 OrganOx: Geographic Presence
59 Organ Assist: Company Snapshot
60 Organ Assist: SWOT Analysis
61 Organ Assist: Geographic Presence
62 Waters Medical Systems LLC: Company Snapshot
63 Waters Medical Systems LLC: SWOT Analysis
64 Waters Medical Systems LLC: Geographic Presence
65 Preservation Sciences, Inc.: Company Snapshot
66 Preservation Sciences, Inc.: SWOT Analysis
67 Preservation Sciences, Inc.: Geographic Presence
68 Other Companies: Company Snapshot
69 Other Companies: SWOT Analysis
70 Other Companies: Geographic Presence
The Global Hypothermic Perfusion Preservation Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Hypothermic Perfusion Preservation Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
